Reference
Yurttas NO, et al. Hepatitis B virus seropositivity in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors: Preliminary results of a single-center cross-sectional study. Blood 130 (Suppl. 1): Dec 2017 [abstract] - Turkey
Rights and permissions
About this article
Cite this article
Dasatinib/nilotinib. Reactions Weekly 1695, 147 (2018). https://doi.org/10.1007/s40278-018-43974-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43974-8